{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Applied Molecular Evolution", "item": "https://www.patentleaderboard.com/2021/company/applied-molecular-evolution"}, {"@type": "ListItem", "position": 4, "name": "Michael W. Lark", "item": "https://www.patentleaderboard.com/2021/inventor/fl:mi_ln:lark-2"}]}

Home › 2021 › Applied Molecular Evolution › Michael W. Lark

Michael W. Lark — 1 Patent in 2021

AEApplied Molecular Evolution: 1 patents #1 of 15Top 7%

Johnson & Johnson: 1 patents #487 of 1,204Top 45%

Devon, PA: #5 of 13 inventorsTop 40%

Pennsylvania: #2,483 of 7,685 inventorsTop 35%

Overall (2021): #331,547 of 548,734Top 65%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11180549	Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody	Yan Chen, Debra Gardner, David Knight, Bailin Liang, David Matthew Marquis +9 more	2021-11-23	$199,606,000

Michael W. Lark — 1 Patent in 2021

Issued Patents 2021

Patent Widget